Carole Nuechterlein

Insider Reports History

Location
Bannockburn, IL
Signature
/s/ Lesley Ann Calhoun, as attorney-in fact for Carole Nuechterlein
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Carole Nuechterlein:

Company Role Class Num Shares Value Price $ Report Date Ownership
Entrada Therapeutics, Inc. Director Stock Option (Right to Buy) 11,918 02 Jun 2022 Direct
Aligos Therapeutics, Inc. Director Stock Option (Right to Buy) 5,860 25 Jun 2025 Direct

Insider Reports Filed by Carole Nuechterlein

Symbol Company Period Transactions Value $ Form Type Role Filing Time
ALGS Aligos Therapeutics, Inc. 25 Jun 2025 1 $0 4 Director 26 Jun 2025, 16:31
ALGS Aligos Therapeutics, Inc. 27 Jun 2024 1 $0 4 Director 28 Jun 2024, 16:08
ALGS Aligos Therapeutics, Inc. 27 Feb 2024 2 $0 4 Director 28 Feb 2024, 17:29
ALGS Aligos Therapeutics, Inc. 25 Oct 2023 2 +$6,499,999 4 Director, 10%+ Owner 27 Oct 2023, 16:15
ALGS Aligos Therapeutics, Inc. 20 Jul 2023 1 $0 4 Director 21 Jul 2023, 16:10
ALGS Aligos Therapeutics, Inc. 23 Jun 2022 1 $0 4 Director 27 Jun 2022, 16:12
TRDA Entrada Therapeutics, Inc. 02 Jun 2022 1 $0 4 Director 06 Jun 2022, 16:01
TRDA Entrada Therapeutics, Inc. 28 Oct 2021 1 $0 4 Director 01 Nov 2021, 19:00
TRDA Entrada Therapeutics, Inc. 28 Oct 2021 0 $0 3 Director 28 Oct 2021, 20:54
ALGS Aligos Therapeutics, Inc. 17 Jun 2021 1 $0 4 Director 17 Jun 2021, 17:09